fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ECCO 2018: Evolving concepts of IBD pathogenesis

Written by | 1 Mar 2018

Perianal fistula is a debilitating complication in CD which affects up to 50% of patients in the course of their disease…

ECCO 2018: Novel treatments in IBD

Written by | 11 Feb 2018

The current research and development pipeline of novel biologic therapies and small molecule drugs promises improved efficacy and safety in the treatment of IBD in the near future…. read more.

ESCP 2017: Multidisciplinary decision-making for colectomy: the difficult patient 

Written by | 11 Oct 2017

By Maria Dalby (article) and Peter Mas Mollinedo (interviews) The decision to perform a colectomy in patients with ulcerative colitis (UC) should not be made lightly. Such a… read more.

ESCP 2017: Innovations in fistula management: stem cell therapy

Written by | 3 Oct 2017

By Maria Dalby (article) and Peter Mas Mollinedo (interviews) In an overview of the immunological rationale for, and clinical application of adipose-derived mesenchymal stem cell (MSC) therapies, Dr… read more.

Maximising bang for your buck in IBD

Written by | 11 Apr 2017

Dr Peter Irving (London) talks about one of the hot topics for the future -Maximising the bang for your buck in IBD. He highlights the possible benefits of treating… read more.

Vulnerable patients: burning questions in IBD

Written by | 30 Mar 2017

An interesting session at ECCO dealt with the patients for whom there is sparce data to guide their treatment – experts in the field gave their guidance to… read more.

New compounds in the treatment of IBD (ECCO 2017)

Written by | 17 Mar 2017

Never before in the history of IBD have there been so many promising compounds in the pipeline. In a scientific session dedicated to new compounds, leading investigators discussed… read more.

Clinical trials vs real life

Written by | 15 Mar 2017

Dr Filip Baert (Roeselare, Belgium) gives a summary of his session on trial endpoints vs therapeutic objectives. he also discusses the role of ECCO in improving the data generated in… read more.

World Health Matters: Germany: Concern over hepatitis B among refugees

Written by | 5 Sep 2016

by Gary Finnegan: People seeking refuge and asylum in Germany are at higher risks of liver problems due to hepatitis B, according to experts.

ILTS 2016: Professors John Lake (University of Minnesota, MN, USA) and John O’Grady (Kings College Hospital, London) discuss what’s novel in immuno-suppression. Also associated article included on Immunosuppression.

Written by | 13 Jun 2016

Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.

ILTS 2016: Professors John Lake (University of Minnesota, MN, USA) and John O’Grady (Kings College Hospital, London) discuss what's novel in immuno-suppression. Also associated article included on Immunosuppression.

Written by | 13 Jun 2016

Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.

ECCO 2016: Professor Stefan Schreiber (Kiel, Germany) discusses some of the issues in managing Crohn’s disease.

Written by | 20 May 2016

In it for the long haul – managing the complexity of Crohn’s disease by Maria Dalby Michael Kamm (Melbourne, Australia), Remo Panaccione (Alberta, Canada) and Stefan Schreiber (Kiel,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.